WBIO:CC News and Press, Wpd Pharmaceuticals Inc - Ordinary Shares From 09/20/22

Vancouver, British Columbia--(Newsfile Corp. - September 20, 2022) - WPD Pharmaceuticals Inc. (CSE: WBIO) (FSE: 8SV1) (the "Company" or "WPD" ) a clinical-stage pharmaceutical company announces that the Company's Board of Directors (the "Board") has approved the raise of WPD Pharmaceutica...

Toronto, Ontario--(Newsfile Corp. - Le 11 juillet/July 2022) - Effective immediately, the following companies are suspended pursuant to CSE Policy 3. The suspensions are considered Regulatory Halts as defined in National Instrument 23-101 Trading Rules. Cease Trade Orders have been issued by ...

IIROC Trading Halt - WBIO Canada NewsWire VANCOUVER, BC , July 11, 2022 /CNW/ - The following issues have been halted by IIROC: Company: WPD Pharmaceuticals Inc. CSE Symbol: WBIO All Issues: Yes Reason: Cease Trade Order Halt T...

VANCOUVER, British Columbia, May 16, 2022 (GLOBE NEWSWIRE) -- WPD Pharmaceuticals Inc. (CSE: WBIO)(FSE: 8SV1) (the “Company” or “WPD” ) a clinical-stage pharmaceutical company, is excited to announce that it has signed Annex No. 2 into its License...